Claus U. Pietrzik - Publications

Affiliations: 
1998-2003 Pathobiochemistry University of Mainz, Germany, Mainz, Rheinland-Pfalz, Germany 

101 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Fritzen L, Wienken K, Wagner L, Kurtyka M, Vogel K, Körbelin J, Weggen S, Fricker G, Pietrzik CU. Truncated mini LRP1 transports cargo from luminal to basolateral side across the blood brain barrier. Fluids and Barriers of the Cns. 21: 74. PMID 39289695 DOI: 10.1186/s12987-024-00573-1  0.582
2024 Armbrust F, Bickenbach K, Altmeppen H, Foggetti A, Winkelmann A, Wulff P, Glatzel M, Pietrzik CU, Becker-Pauly C. A novel mouse model for N-terminal truncated Aβ2-x generation through meprin β overexpression in astrocytes. Cellular and Molecular Life Sciences : Cmls. 81: 139. PMID 38480559 DOI: 10.1007/s00018-024-05139-w  0.374
2023 Kurth V, Ogorek I, Münch C, Lopez-Rios J, Ousson S, Lehmann S, Nieweg K, Roebroek AJM, Pietrzik CU, Beher D, Weggen S. Pathogenic Aβ production by heterozygous PSEN1 mutations is intrinsic to the mutant protein and not mediated by conformational hindrance of wild type PSEN1. The Journal of Biological Chemistry. 104997. PMID 37394008 DOI: 10.1016/j.jbc.2023.104997  0.655
2023 Klecker PH, Fritzen L, Mazura AD, Weggen S, Pietrzik CU. Antibody-mediated inhibition of tissue-type plasminogen activator binding to the low-density lipoprotein receptor-related protein 1 as a potential beneficial modulator for stroke therapy. Journal of Cellular Biochemistry. PMID 37288821 DOI: 10.1002/jcb.30431  0.587
2023 Ulku I, Liebsch F, Akerman SC, Schulz JF, Kulic L, Hock C, Pietrzik C, Di Spiezio A, Thinakaran G, Saftig P, Multhaup G. Mechanisms of amyloid-β34 generation indicate a pivotal role for BACE1 in amyloid homeostasis. Scientific Reports. 13: 2216. PMID 36750595 DOI: 10.1038/s41598-023-28846-z  0.438
2022 Mazura AD, Ohler A, Storck SE, Kurtyka M, Scharfenberg F, Weggen S, Becker-Pauly C, Pietrzik CU. PCSK9 acts as a key regulator of Aβ clearance across the blood-brain barrier. Cellular and Molecular Life Sciences : Cmls. 79: 212. PMID 35344086 DOI: 10.1007/s00018-022-04237-x  0.667
2022 Marengo L, Armbrust F, Schoenherr C, Storck SE, Schmitt U, Zampar S, Wirths O, Altmeppen H, Glatzel M, Kaether C, Weggen S, Becker-Pauly C, Pietrzik CU. Meprin β knockout reduces brain Aβ levels and rescues learning and memory impairments in the APP/lon mouse model for Alzheimer's disease. Cellular and Molecular Life Sciences : Cmls. 79: 168. PMID 35235058 DOI: 10.1007/s00018-022-04205-5  0.666
2021 Armbrust F, Bickenbach K, Marengo L, Pietrzik C, Becker-Pauly C. The Swedish dilemma - the almost exclusive use of APPswe-based mouse models impedes adequate evaluation of alternative β-secretases. Biochimica Et Biophysica Acta. Molecular Cell Research. 1869: 119164. PMID 34699873 DOI: 10.1016/j.bbamcr.2021.119164  0.371
2021 Storck SE, Hartz AMS, Pietrzik CU. The Blood-Brain Barrier in Alzheimer's Disease. Handbook of Experimental Pharmacology. PMID 33580390 DOI: 10.1007/164_2020_418  0.317
2020 Bres EE, Safina D, Müller J, Bedner P, Yang H, Helluy X, Shchyglo O, Jansen S, Mark MD, Esser A, Steinhäuser C, Herlitze S, Pietrzik CU, Sirko S, Manahan-Vaughan D, et al. Lipoprotein receptor loss in forebrain radial glia results in neurological deficits and severe seizures. Glia. PMID 32579270 DOI: 10.1002/Glia.23869  0.339
2019 Scharfenberg F, Helbig A, Sammel M, Benzel J, Schlomann U, Peters F, Wichert R, Bettendorff M, Schmidt-Arras D, Rose-John S, Moali C, Lichtenthaler SF, Pietrzik CU, Bartsch JW, Tholey A, et al. Degradome of soluble ADAM10 and ADAM17 metalloproteases. Cellular and Molecular Life Sciences : Cmls. PMID 31209506 DOI: 10.1007/S00018-019-03184-4  0.316
2019 Scharfenberg F, Armbrust F, Marengo L, Pietrzik C, Becker-Pauly C. Regulation of the alternative β-secretase meprin β by ADAM-mediated shedding. Cellular and Molecular Life Sciences : Cmls. 76: 3193-3206. PMID 31201463 DOI: 10.1007/S00018-019-03179-1  0.414
2019 Van Gool B, Storck SE, Reekmans SM, Lechat B, Gordts PLSM, Pradier L, Pietrzik CU, Roebroek AJM. LRP1 Has a Predominant Role in Production over Clearance of Aβ in a Mouse Model of Alzheimer's Disease. Molecular Neurobiology. PMID 31004319 DOI: 10.1007/S12035-019-1594-2  0.512
2019 Peters F, Scharfenberg F, Colmorgen C, Armbrust F, Wichert R, Arnold P, Potempa B, Potempa J, Pietrzik CU, Häsler R, Rosenstiel P, Becker-Pauly C. Tethering soluble meprin α in an enzyme complex to the cell surface affects IBD-associated genes. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201802391R. PMID 30916990 DOI: 10.1096/Fj.201802391R  0.312
2018 Walter S, Jumpertz T, Hüttenrauch M, Ogorek I, Gerber H, Storck SE, Zampar S, Dimitrov M, Lehmann S, Lepka K, Berndt C, Wiltfang J, Becker-Pauly C, Beher D, Pietrzik CU, et al. The metalloprotease ADAMTS4 generates N-truncated Aβ4-x species and marks oligodendrocytes as a source of amyloidogenic peptides in Alzheimer's disease. Acta Neuropathologica. PMID 30426203 DOI: 10.1007/S00401-018-1929-5  0.691
2018 Storck SE, Hartz AMS, Bernard J, Wolf A, Kachlmeier A, Mahringer A, Weggen S, Pahnke J, Pietrzik CU. The concerted amyloid-beta clearance of LRP1 and ABCB1/P-gp across the blood-brain barrier is linked by PICALM. Brain, Behavior, and Immunity. PMID 30041013 DOI: 10.1016/J.Bbi.2018.07.017  0.668
2018 Goel P, Jumpertz T, Tichá A, Ogorek I, Mikles DC, Hubalek M, Pietrzik CU, Strisovsky K, Schmidt B, Weggen S. Discovery and validation of 2-styryl substituted benzoxazin-4-ones as a novel scaffold for rhomboid protease inhibitors. Bioorganic & Medicinal Chemistry Letters. PMID 29463448 DOI: 10.1016/J.Bmcl.2018.02.017  0.594
2018 Storck SE, Pietrzik CU. The Blood brain-barrier and its role in Alzheimer’s disease Neuroforum. 24: A197-A205. DOI: 10.1515/Nf-2018-A014  0.383
2018 Storck SE, Pietrzik CU. Die Blut-Hirn-Schranke und ihre Rolle in der Alzheimer – Krankheit Neuroforum. 24: 287-296. DOI: 10.1515/Nf-2018-0014  0.373
2017 Goel P, Jumpertz T, Mikles DC, Tichá A, Nguyen MTN, Verhelst S, Hubalek M, Johnson DC, Bachovchin DA, Ogorek I, Pietrzik CU, Strisovsky K, Schmidt B, Weggen S. Discovery and Biological Evaluation of Potent and Selective N-Methylene Saccharin-Derived Inhibitors for Rhomboid Intramembrane Proteases. Biochemistry. PMID 29185711 DOI: 10.1021/Acs.Biochem.7B01066  0.6
2017 Storck SE, Pietrzik CU. Endothelial LRP1 - A Potential Target for the Treatment of Alzheimer's Disease. Pharmaceutical Research. PMID 28948494 DOI: 10.1007/S11095-017-2267-3  0.476
2017 Zandl-Lang M, Fanaee-Danesh E, Sun Y, Čančar I, Gali CC, Kober A, Albrecher NM, Tam-Amersdorfer C, Stracke A, Storck S, Saeed A, Stefulj J, Pietrzik C, Wilson MR, Björkhem I, et al. Regulatory effects of simvastatin and apoJ on APP processing and amyloid-β clearance in blood-brain barrier endothelial cells. Biochimica Et Biophysica Acta. PMID 28941799 DOI: 10.1016/J.Bbalip.2017.09.008  0.517
2017 Eggert S, Gonzalez AC, Thomas C, Schilling S, Schwarz SM, Tischer C, Adam V, Strecker P, Schmidt V, Willnow TE, Hermey G, Pietrzik CU, Koo EH, Kins S. Dimerization leads to changes in APP (amyloid precursor protein) trafficking mediated by LRP1 and SorLA. Cellular and Molecular Life Sciences : Cmls. PMID 28799085 DOI: 10.1007/S00018-017-2625-7  0.809
2017 Steffen J, Krohn M, Schwitlick C, Brüning T, Paarmann K, Pietrzik CU, Biverstål H, Jansone B, Langer O, Pahnke J. Expression of endogenous mouse APP modulates β-amyloid deposition in hAPP-transgenic mice. Acta Neuropathologica Communications. 5: 49. PMID 28637503 DOI: 10.1186/S40478-017-0448-2  0.46
2017 Herr UM, Strecker P, Storck SE, Thomas C, Rabiej V, Junker A, Schilling S, Schmidt N, Dowds CM, Eggert S, Pietrzik CU, Kins S. LRP1 Modulates APP Intraneuronal Transport and Processing in Its Monomeric and Dimeric State. Frontiers in Molecular Neuroscience. 10: 118. PMID 28496400 DOI: 10.3389/fnmol.2017.00118  0.728
2017 Wild K, August A, Pietrzik CU, Kins S. Structure and Synaptic Function of Metal Binding to the Amyloid Precursor Protein and its Proteolytic Fragments. Frontiers in Molecular Neuroscience. 10: 21. PMID 28197076 DOI: 10.3389/Fnmol.2017.00021  0.445
2016 Becker-Pauly C, Pietrzik CU. The Metalloprotease Meprin β Is an Alternative β-Secretase of APP. Frontiers in Molecular Neuroscience. 9: 159. PMID 28105004 DOI: 10.3389/Fnmol.2016.00159  0.405
2016 Brandscheid C, Schuck F, Reinhardt S, Schäfer KH, Pietrzik CU, Grimm M, Hartmann T, Schwiertz A, Endres K. Altered Gut Microbiome Composition and Tryptic Activity of the 5xFAD Alzheimer's Mouse Model. Journal of Alzheimer's Disease : Jad. PMID 28035935 DOI: 10.3233/Jad-160926  0.371
2016 Becker-Pauly C, Pietrzik CU. Mice are not Men: ADAM30 Findings Emphasize a Broader Look Towards Murine Alzheimer's Disease Models. Ebiomedicine. PMID 27396345 DOI: 10.1016/J.Ebiom.2016.06.035  0.479
2016 Safina D, Schlitt F, Romeo R, Pflanzner T, Pietrzik CU, Narayanaswami V, Edenhofer F, Faissner A. Low-density lipoprotein receptor-related protein 1 is a novel modulator of radial glia stem cell proliferation, survival, and differentiation. Glia. PMID 27258849 DOI: 10.1002/Glia.23009  0.311
2016 Schmidt F, Müller M, Prox J, Arnold P, Schönherr C, Tredup C, Minder P, Ebsen H, Janssen O, Annaert W, Pietrzik C, Schmidt-Arras D, Sterchi EE, Becker-Pauly C. Tetraspanin 8 is an interactor of the metalloprotease meprin β within tetraspanin-enriched microdomains. Biological Chemistry. PMID 27180357 DOI: 10.1515/Hsz-20-2016-0126  0.355
2016 Schönherr C, Bien J, Isbert S, Wichert R, Prox J, Altmeppen H, Kumar S, Walter J, Lichtenthaler SF, Weggen S, Glatzel M, Becker-Pauly C, Pietrzik CU. Generation of aggregation prone N-terminally truncated amyloid β peptides by meprin β depends on the sequence specificity at the cleavage site. Molecular Neurodegeneration. 11: 19. PMID 26895626 DOI: 10.1186/S13024-016-0084-5  0.674
2016 Storck S, Vandenbroucke RE, Weggen S, Schwaninger M, Bayer T, Pietrzik CU. O4-11-05: Endothelial-LRP1 Clears Major Amounts of Abeta 1-42 Across the Blood-Brain Barrier Alzheimer's & Dementia. 12: P361-P362. DOI: 10.1016/J.Jalz.2016.06.670  0.631
2015 Storck SE, Meister S, Nahrath J, Meißner JN, Schubert N, Di Spiezio A, Baches S, Vandenbroucke RE, Bouter Y, Prikulis I, Korth C, Weggen S, Heimann A, Schwaninger M, Bayer TA, ... Pietrzik CU, et al. Endothelial LRP1 transports amyloid-β1-42 across the blood-brain barrier. The Journal of Clinical Investigation. PMID 26619118 DOI: 10.1172/Jci81108  0.682
2015 Rabiej VK, Pflanzner T, Wagner T, Götze K, Storck S, Eble JA, Weggen S, Mueller-Klieser W, Pietrzik CU. Low density lipoprotein receptor-related protein 1 mediated endocytosis of β1-integrin influences cell adhesion and cell migration. Experimental Cell Research. PMID 26610862 DOI: 10.1016/J.Yexcr.2015.11.020  0.618
2015 Jäckle F, Schmidt F, Wichert R, Arnold P, Prox J, Mangold M, Ohler A, Pietrzik CU, Koudelka T, Tholey A, Gütschow M, Stirnberg M, Becker-Pauly C. Metalloprotease meprin β is activated by transmembrane serine protease matriptase-2 at the cell surface thereby enhancing APP shedding. The Biochemical Journal. 470: 91-103. PMID 26251449 DOI: 10.1042/Bj20141417  0.39
2015 Arnold P, Schmidt F, Prox J, Zunke F, Pietrzik C, Lucius R, Becker-Pauly C. Calcium negatively regulates meprin β activity and attenuates substrate cleavage. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 29: 3549-57. PMID 25957281 DOI: 10.1096/Fj.15-272310  0.337
2015 Meister S, Storck SE, Hameister E, Behl C, Weggen S, Clement AM, Pietrzik CU. Expression of the ALS-causing variant hSOD1(G93A) leads to an impaired integrity and altered regulation of claudin-5 expression in an in vitro blood-spinal cord barrier model. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 35: 1112-21. PMID 25853911 DOI: 10.1038/Jcbfm.2015.57  0.6
2014 Tucher J, Linke D, Koudelka T, Cassidy L, Tredup C, Wichert R, Pietrzik C, Becker-Pauly C, Tholey A. LC-MS based cleavage site profiling of the proteases ADAM10 and ADAM17 using proteome-derived peptide libraries. Journal of Proteome Research. 13: 2205-14. PMID 24635658 DOI: 10.1021/Pr401135U  0.316
2013 Meister S, Zlatev I, Stab J, Docter D, Baches S, Stauber RH, Deutsch M, Schmidt R, Ropele S, Windisch M, Langer K, Wagner S, von Briesen H, Weggen S, Pietrzik CU. Nanoparticulate flurbiprofen reduces amyloid-β42 generation in an in vitro blood-brain barrier model. Alzheimer's Research & Therapy. 5: 51. PMID 24280275 DOI: 10.1186/Alzrt225  0.654
2013 Maier W, Bednorz M, Meister S, Roebroek A, Weggen S, Schmitt U, Pietrzik CU. LRP1 is critical for the surface distribution and internalization of the NR2B NMDA receptor subtype. Molecular Neurodegeneration. 8: 25. PMID 23866919 DOI: 10.1186/1750-1326-8-25  0.604
2013 Wagner T, Dieckmann M, Jaeger S, Weggen S, Pietrzik CU. Stx5 is a novel interactor of VLDL-R to affect its intracellular trafficking and processing. Experimental Cell Research. 319: 1956-72. PMID 23701949 DOI: 10.1016/J.Yexcr.2013.05.010  0.603
2013 Gil SY, Youn BS, Byun K, Huang H, Namkoong C, Jang PG, Lee JY, Jo YH, Kang GM, Kim HK, Shin MS, Pietrzik CU, Lee B, Kim YB, Kim MS. Clusterin and LRP2 are critical components of the hypothalamic feeding regulatory pathway. Nature Communications. 4: 1862. PMID 23673647 DOI: 10.1038/Ncomms2896  0.326
2013 Jefferson T, Auf Dem Keller U, Bellac C, Metz VV, Broder C, Hedrich J, Ohler A, Maier W, Magdolen V, Sterchi E, Bond JS, Jayakumar A, Traupe H, Chalaris A, Rose-John S, ... Pietrzik CU, et al. The substrate degradome of meprin metalloproteases reveals an unexpected proteolytic link between meprin β and ADAM10 Cellular and Molecular Life Sciences. 70: 309-333. PMID 22940918 DOI: 10.1007/S00018-012-1106-2  0.353
2012 Rennhack A, Jumpertz T, Ness J, Baches S, Pietrzik CU, Weggen S, Bulic B. Synthesis of a potent photoreactive acidic γ-secretase modulator for target identification in cells. Bioorganic & Medicinal Chemistry. 20: 6523-32. PMID 23000293 DOI: 10.1016/J.Bmc.2012.08.034  0.708
2012 Bien J, Jefferson T, Causević M, Jumpertz T, Munter L, Multhaup G, Weggen S, Becker-Pauly C, Pietrzik CU. The metalloprotease meprin β generates amino terminal-truncated amyloid β peptide species. The Journal of Biological Chemistry. 287: 33304-13. PMID 22879596 DOI: 10.1074/Jbc.M112.395608  0.725
2012 Zettl H, Ness J, Hähnke V, Beher D, Jumpertz T, Saric A, Baumann K, Pietrzik CU, Bulic B, Schneider G, Weggen S. Discovery of γ-secretase modulators with a novel activity profile by text-based virtual screening. Acs Chemical Biology. 7: 1488-95. PMID 22725102 DOI: 10.1021/Cb3001952  0.648
2012 Wagner S, Zensi A, Wien SL, Tschickardt SE, Maier W, Vogel T, Worek F, Pietrzik CU, Kreuter J, von Briesen H. Uptake mechanism of ApoE-modified nanoparticles on brain capillary endothelial cells as a blood-brain barrier model. Plos One. 7: e32568. PMID 22396775 DOI: 10.1371/Journal.Pone.0032568  0.304
2012 Müller UC, Pietrzik CU, Deller T. The physiological functions of the β-amyloid precursor protein APP. Experimental Brain Research. 217: 325-9. PMID 22349563 DOI: 10.1007/S00221-012-3039-2  0.466
2012 Pflanzner T, Petsch B, André-Dohmen B, Müller-Schiffmann A, Tschickardt S, Weggen S, Stitz L, Korth C, Pietrzik CU. Cellular prion protein participates in amyloid-β transcytosis across the blood-brain barrier. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 32: 628-32. PMID 22293988 DOI: 10.1038/Jcbfm.2012.7  0.663
2012 Jumpertz T, Rennhack A, Ness J, Baches S, Pietrzik CU, Bulic B, Weggen S. Presenilin is the molecular target of acidic γ-secretase modulators in living cells. Plos One. 7: e30484. PMID 22238696 DOI: 10.1371/Journal.Pone.0030484  0.679
2012 Isbert S, Wagner K, Eggert S, Schweitzer A, Multhaup G, Weggen S, Kins S, Pietrzik CU. APP dimer formation is initiated in the endoplasmic reticulum and differs between APP isoforms. Cellular and Molecular Life Sciences : Cmls. 69: 1353-75. PMID 22105709 DOI: 10.1007/S00018-011-0882-4  0.796
2012 Wagner T, Pietrzik CU. The role of lipoprotein receptors on the physiological function of APP. Experimental Brain Research. 217: 377-87. PMID 21947084 DOI: 10.1007/S00221-011-2876-8  0.371
2012 Bien J, Jefferson T, Causevic M, Jumpertz T, Munter LM, Multhaup G, Weggen S, Becker-Pauly C, Pietrzik C. O2-04-04: The metalloprotease meprin beta generates amino-terminally truncated beta-amyloid peptide species Alzheimer's & Dementia. 8: P242-P242. DOI: 10.1016/J.Jalz.2012.05.643  0.641
2011 Jefferson T, ÄŒauÅ¡ević M, auf dem Keller U, Schilling O, Isbert S, Geyer R, Maier W, Tschickardt S, Jumpertz T, Weggen S, Bond JS, Overall CM, Pietrzik CU, Becker-Pauly C. Metalloprotease meprin beta generates nontoxic N-terminal amyloid precursor protein fragments in vivo. The Journal of Biological Chemistry. 286: 27741-50. PMID 21646356 DOI: 10.1074/Jbc.M111.252718  0.707
2011 Heneka MT, Kummer MP, Weggen S, Bulic B, Multhaup G, Münter L, Hüll M, Pflanzner T, Pietrzik CU. Molecular mechanisms and therapeutic application of NSAIDs and derived compounds in Alzheimer's disease. Current Alzheimer Research. 8: 115-31. PMID 21345168 DOI: 10.2174/156720511795256099  0.774
2011 Rolyan H, Feike AC, Upadhaya AR, Waha A, Van Dooren T, Haass C, Birkenmeier G, Pietrzik CU, Van Leuven F, Thal DR. Amyloid-β protein modulates the perivascular clearance of neuronal apolipoprotein E in mouse models of Alzheimer's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 118: 699-712. PMID 21210284 DOI: 10.1007/S00702-010-0572-7  0.414
2011 Hahn S, Brüning T, Ness J, Czirr E, Baches S, Gijsen H, Korth C, Pietrzik CU, Bulic B, Weggen S. Presenilin-1 but not amyloid precursor protein mutations present in mouse models of Alzheimer's disease attenuate the response of cultured cells to γ-secretase modulators regardless of their potency and structure. Journal of Neurochemistry. 116: 385-95. PMID 21091478 DOI: 10.1111/J.1471-4159.2010.07118.X  0.671
2011 Pflanzner T, Janko MC, André-Dohmen B, Reuss S, Weggen S, Roebroek AJ, Kuhlmann CR, Pietrzik CU. LRP1 mediates bidirectional transcytosis of amyloid-β across the blood-brain barrier. Neurobiology of Aging. 32: 2323.e1-11. PMID 20630619 DOI: 10.1016/J.Neurobiolaging.2010.05.025  0.678
2010 Pflanzner T, Kuhlmann CR, Pietrzik CU. Blood-brain-barrier models for the investigation of transporter- and receptor-mediated amyloid-β clearance in Alzheimer's disease Current Alzheimer Research. 7: 578-590. PMID 20704558 DOI: 10.2174/156720510793499066  0.455
2010 Reekmans SM, Pflanzner T, Gordts PL, Isbert S, Zimmermann P, Annaert W, Weggen S, Roebroek AJ, Pietrzik CU. Inactivation of the proximal NPXY motif impairs early steps in LRP1 biosynthesis. Cellular and Molecular Life Sciences : Cmls. 67: 135-45. PMID 19856143 DOI: 10.1007/S00018-009-0171-7  0.615
2009 Jäger S, Leuchtenberger S, Martin A, Czirr E, Wesselowski J, Dieckmann M, Waldron E, Korth C, Koo EH, Heneka M, Weggen S, Pietrzik CU. alpha-secretase mediated conversion of the amyloid precursor protein derived membrane stub C99 to C83 limits Abeta generation. Journal of Neurochemistry. 111: 1369-82. PMID 19804379 DOI: 10.1111/J.1471-4159.2009.06420.X  0.762
2009 Kuhlmann CR, Librizzi L, Closhen D, Pflanzner T, Lessmann V, Pietrzik CU, de Curtis M, Luhmann HJ. Mechanisms of C-reactive protein-induced blood-brain barrier disruption. Stroke; a Journal of Cerebral Circulation. 40: 1458-66. PMID 19246692 DOI: 10.1161/Strokeaha.108.535930  0.331
2009 Leuchtenberger S, Maler J, Czirr E, Ness J, Lichtenthaler SF, Esselmann H, Pietrzik CU, Wiltfang J, Weggen S. Nonsteroidal anti-inflammatory drugs and ectodomain shedding of the amyloid precursor protein. Neuro-Degenerative Diseases. 6: 1-8. PMID 18349521 DOI: 10.1159/000121391  0.669
2009 Lehmann S, Bruening T, Ness J, Czirr E, Bulic B, Pietrzik CU, Weggen S. P3-271: Presenilin-1 (PS1) and amyloid precursor protein (APP) mutations present in mouse models of Alzheimer's disease in their response to γ-secretase inhibitors and modulators Alzheimer's & Dementia. 5: P422-P423. DOI: 10.1016/J.Jalz.2009.04.942  0.697
2009 Ness JS, Riemenschneider MJ, Baches S, Eriksen JL, Pietrzik CU, Reifenberger G, Weggen S. P4-244: Progranulin (GRN), a protein mutated in frontotemporal dementia with ubiquitin-positive inclusions (FTLD-U), is abundantly expressed in human gliomas Alzheimer's & Dementia. 5: P502-P502. DOI: 10.1016/J.Jalz.2009.04.710  0.612
2008 Tamboli IY, Prager K, Thal DR, Thelen KM, Dewachter I, Pietrzik CU, St George-Hyslop P, Sisodia SS, De Strooper B, Heneka MT, Filippov MA, Müller U, van Leuven F, Lütjohann D, Walter J. Loss of gamma-secretase function impairs endocytosis of lipoprotein particles and membrane cholesterol homeostasis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 12097-106. PMID 19005074 DOI: 10.1523/Jneurosci.2635-08.2008  0.404
2008 Utter S, Tamboli IY, Walter J, Upadhaya AR, Birkenmeier G, Pietrzik CU, Ghebremedhin E, Thal DR. Cerebral small vessel disease-induced apolipoprotein E leakage is associated with Alzheimer disease and the accumulation of amyloid beta-protein in perivascular astrocytes. Journal of Neuropathology and Experimental Neurology. 67: 842-56. PMID 18716559 DOI: 10.1097/Nen.0B013E3181836A71  0.46
2008 Waldron E, Heilig C, Schweitzer A, Nadella N, Jaeger S, Martin AM, Weggen S, Brix K, Pietrzik CU. LRP1 modulates APP trafficking along early compartments of the secretory pathway. Neurobiology of Disease. 31: 188-97. PMID 18559293 DOI: 10.1016/J.Nbd.2008.04.006  0.715
2008 Waldron E, Isbert S, Kern A, Jaeger S, Martin AM, Hébert SS, Behl C, Weggen S, De Strooper B, Pietrzik CU. Increased AICD generation does not result in increased nuclear translocation or activation of target gene transcription. Experimental Cell Research. 314: 2419-33. PMID 18559276 DOI: 10.1016/J.Yexcr.2008.05.003  0.665
2008 Czirr E, Cottrell BA, Leuchtenberger S, Kukar T, Ladd TB, Esselmann H, Paul S, Schubenel R, Torpey JW, Pietrzik CU, Golde TE, Wiltfang J, Baumann K, Koo EH, Weggen S. Independent generation of Abeta42 and Abeta38 peptide species by gamma-secretase. The Journal of Biological Chemistry. 283: 17049-54. PMID 18426795 DOI: 10.1074/Jbc.M802912200  0.766
2008 Martin AM, Kuhlmann C, Trossbach S, Jaeger S, Waldron E, Roebroek A, Luhmann HJ, Laatsch A, Weggen S, Lessmann V, Pietrzik CU. The functional role of the second NPXY motif of the LRP1 beta-chain in tissue-type plasminogen activator-mediated activation of N-methyl-D-aspartate receptors. The Journal of Biological Chemistry. 283: 12004-13. PMID 18321860 DOI: 10.1074/Jbc.M707607200  0.62
2008 Jaeger S, Pietrzik CU. Functional role of lipoprotein receptors in Alzheimer's disease. Current Alzheimer Research. 5: 15-25. PMID 18288927 DOI: 10.2174/156720508783884675  0.542
2008 Thal DR, Tamboli IY, Walter J, Birkenmeier G, Pietrzik CU, Utter S. P4-295: Small vessel disease–induced microvascular protein leakage provides a possible pathogenetic link to Alzheimer's disease Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.2364  0.363
2008 Czirr E, Cottrell BA, Serneels L, Leuchtenberger S, Schubenel R, Torpey JW, Esselmann H, Pietrzik CU, Wiltfang J, DeStrooper B, Baumann K, Koo EH, Weggen S. P4-192: Mechanism of γ-secretase cleavage: Evidence for independent generation of Aβ42 and Aβ38 peptide species Alzheimer's & Dementia. 4: T727-T728. DOI: 10.1016/J.Jalz.2008.05.2259  0.733
2008 Pietrzik CU, Jaeger S, Wesselowski J, Cirr E, Korth C, Weggen S, Koo EH, Pietrzik KF. P3-344: γ-secretase-dependent APP processing occurs either at the plasma membrane or in the endocytic compartments independent of the APP wild-type or APP Swedish variant Alzheimer's & Dementia. 4: T622-T622. DOI: 10.1016/J.Jalz.2008.05.1913  0.715
2007 Ring S, Weyer SW, Kilian SB, Waldron E, Pietrzik CU, Filippov MA, Herms J, Buchholz C, Eckman CB, Korte M, Wolfer DP, Müller UC. The secreted beta-amyloid precursor protein ectodomain APPs alpha is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 7817-26. PMID 17634375 DOI: 10.1523/Jneurosci.1026-07.2007  0.524
2007 Czirr E, Leuchtenberger S, Dorner-Ciossek C, Schneider A, Jucker M, Koo EH, Pietrzik CU, Baumann K, Weggen S. Insensitivity to Abeta42-lowering nonsteroidal anti-inflammatory drugs and gamma-secretase inhibitors is common among aggressive presenilin-1 mutations. The Journal of Biological Chemistry. 282: 24504-13. PMID 17573346 DOI: 10.1074/Jbc.M700618200  0.754
2006 Waldron E, Jaeger S, Pietrzik CU. Functional role of the low-density lipoprotein receptor-related protein in Alzheimer's disease. Neuro-Degenerative Diseases. 3: 233-8. PMID 17047362 DOI: 10.1159/000095261  0.537
2006 Neumann S, Schöbel S, Jäger S, Trautwein A, Haass C, Pietrzik CU, Lichtenthaler SF. Amyloid precursor-like protein 1 influences endocytosis and proteolytic processing of the amyloid precursor protein. The Journal of Biological Chemistry. 281: 7583-94. PMID 16344553 DOI: 10.1074/Jbc.M508340200  0.552
2006 Leuchtenberger S, Kummer MP, Kukar T, Czirr E, Teusch N, Sagi SA, Berdeaux R, Pietrzik CU, Ladd TB, Golde TE, Koo EH, Weggen S. Inhibitors of Rho-kinase modulate amyloid-beta (Abeta) secretion but lack selectivity for Abeta42. Journal of Neurochemistry. 96: 355-65. PMID 16300630 DOI: 10.1111/J.1471-4159.2005.03553.X  0.815
2006 Czirr E, Leuchtenberger S, Schneider A, Koo EH, Pietrzik CU, Weggen S. O1-02-06: Genetic dissection of the PS1-ΔExon9 mutation and its attenuated response to Aβ42-lowering NSAIDs Alzheimer's & Dementia. 2: S11-S12. DOI: 10.1016/J.Jalz.2006.05.258  0.539
2006 Neumann S, Schöbel S, Jäger S, Haass C, Pietrzik CU, Lichtenthaler SF. P4-070: Amyloid precursor-like proteins 1 and 2 influence proteolytic processing of the amyloid precursor protein by alpha- and beta-secretase Alzheimer's & Dementia. 2: S534-S534. DOI: 10.1016/J.Jalz.2006.05.1808  0.436
2006 Jaeger S, Rogge BS, Weggen S, Koo EH, Pietrzik CU. P3-247: Functional consequences of LRP expression on familiar Alzheimer disease APP mutations Alzheimer's & Dementia. 2: S448-S448. DOI: 10.1016/J.Jalz.2006.05.1516  0.592
2005 Lleó A, Waldron E, von Arnim CA, Herl L, Tangredi MM, Peltan ID, Strickland DK, Koo EH, Hyman BT, Pietrzik CU, Berezovska O. Low density lipoprotein receptor-related protein (LRP) interacts with presenilin 1 and is a competitive substrate of the amyloid precursor protein (APP) for gamma-secretase. The Journal of Biological Chemistry. 280: 27303-9. PMID 15917251 DOI: 10.1074/Jbc.M413969200  0.665
2005 Pietrzik C, Behl C. Concepts for the treatment of Alzheimer's disease: molecular mechanisms and clinical application. International Journal of Experimental Pathology. 86: 173-85. PMID 15910551 DOI: 10.1111/J.0959-9673.2005.00435.X  0.358
2005 Goodenough S, Schleusner D, Pietrzik C, Skutella T, Behl C. Glycogen synthase kinase 3beta links neuroprotection by 17beta-estradiol to key Alzheimer processes. Neuroscience. 132: 581-9. PMID 15837120 DOI: 10.1016/J.Neuroscience.2004.12.029  0.37
2005 Yoon IS, Pietrzik CU, Kang DE, Koo EH. Sequences from the low density lipoprotein receptor-related protein (LRP) cytoplasmic domain enhance amyloid beta protein production via the beta-secretase pathway without altering amyloid precursor protein/LRP nuclear signaling. The Journal of Biological Chemistry. 280: 20140-7. PMID 15772078 DOI: 10.1074/Jbc.M413729200  0.781
2004 Pietrzik CU, Yoon IS, Jaeger S, Busse T, Weggen S, Koo EH. FE65 constitutes the functional link between the low-density lipoprotein receptor-related protein and the amyloid precursor protein. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 4259-65. PMID 15115822 DOI: 10.1523/Jneurosci.5451-03.2004  0.73
2004 Pietrzik CU, Jaeger S, Yoon I, Busse T, Weggen S, Koo EH. P3-296 FE65 constitutes the functional link between the LDL receptor-related protein (LRP) and APP Neurobiology of Aging. 25: S439. DOI: 10.1016/S0197-4580(04)81446-5  0.7
2003 Weggen S, Eriksen JL, Sagi SA, Pietrzik CU, Ozols V, Fauq A, Golde TE, Koo EH. Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid beta 42 production by direct modulation of gamma-secretase activity. The Journal of Biological Chemistry. 278: 31831-7. PMID 12805356 DOI: 10.1074/Jbc.M303592200  0.738
2003 Weggen S, Eriksen JL, Sagi SA, Pietrzik CU, Golde TE, Koo EH. Abeta42-lowering nonsteroidal anti-inflammatory drugs preserve intramembrane cleavage of the amyloid precursor protein (APP) and ErbB-4 receptor and signaling through the APP intracellular domain. The Journal of Biological Chemistry. 278: 30748-54. PMID 12777371 DOI: 10.1074/Jbc.M304824200  0.77
2002 Leem JY, Saura CA, Pietrzik C, Christianson J, Wanamaker C, King LT, Veselits ML, Tomita T, Gasparini L, Iwatsubo T, Xu H, Green WN, Koo EH, Thinakaran G. A role for presenilin 1 in regulating the delivery of amyloid precursor protein to the cell surface. Neurobiology of Disease. 11: 64-82. PMID 12460547 DOI: 10.1006/Nbdi.2002.0546  0.645
2002 Pietrzik CU, Busse T, Merriam DE, Weggen S, Koo EH. The cytoplasmic domain of the LDL receptor-related protein regulates multiple steps in APP processing. The Embo Journal. 21: 5691-700. PMID 12411487 DOI: 10.1093/Emboj/Cdf568  0.777
2001 Weggen S, Eriksen JL, Das P, Sagi SA, Wang R, Pietrzik CU, Findlay KA, Smith TE, Murphy MP, Bulter T, Kang DE, Marquez-Sterling N, Golde TE, Koo EH. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature. 414: 212-6. PMID 11700559 DOI: 10.1038/35102591  0.821
2001 Soriano S, Lu DC, Chandra S, Pietrzik CU, Koo EH. The amyloidogenic pathway of amyloid precursor protein (APP) is independent of its cleavage by caspases. The Journal of Biological Chemistry. 276: 29045-50. PMID 11397796 DOI: 10.1074/Jbc.M102456200  0.796
2000 Kang DE, Pietrzik CU, Baum L, Chevallier N, Merriam DE, Kounnas MZ, Wagner SL, Troncoso JC, Kawas CH, Katzman R, Koo EH. Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. The Journal of Clinical Investigation. 106: 1159-66. PMID 11067868 DOI: 10.1172/Jci11013  0.78
1999 Hoffmann J, Pietrzik CU, Kummer MP, Twiesselmann C, Bauer C, Herzog V. Binding and selective detection of the secretory N-terminal domain of the alzheimer amyloid precursor protein on cell surfaces. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 47: 373-82. PMID 10026239 DOI: 10.1177/002215549904700311  0.72
1998 Pietrzik CU, Hoffmann J, Stöber K, Chen CY, Bauer C, Otero DA, Roch JM, Herzog V. From differentiation to proliferation: the secretory amyloid precursor protein as a local mediator of growth in thyroid epithelial cells. Proceedings of the National Academy of Sciences of the United States of America. 95: 1770-5. PMID 9465092 DOI: 10.1073/Pnas.95.4.1770  0.566
1997 Overdick M, Czermak A, Fischer P, Herzog V, Kjensmo A, Kugelmeier T, Ljunggren K, Nygård E, Pietrzik C, Schwan T, Strand S, Straver J, Weilhammer P, Wermes N, Yoshioka K. A “Bioscope” system using double-sided silicon strip detectors and self-triggering read-out chips Nuclear Instruments and Methods in Physics Research Section a: Accelerators, Spectrometers, Detectors and Associated Equipment. 392: 173-177. DOI: 10.1016/S0168-9002(97)00251-9  0.433
1996 Popp GM, Graebert KS, Pietrzik CU, Rosentreter SM, Lemansky P, Herzog V. Growth regulation of rat thyrocytes (FRTL-5 cells) by the secreted ectodomain of beta-amyloid precursor-like proteins. Endocrinology. 137: 1975-83. PMID 8612538 DOI: 10.1210/Endo.137.5.8612538  0.572
Show low-probability matches.